Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2007-10-08
2009-10-13
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
Reexamination Certificate
active
07601521
ABSTRACT:
Methods for detection of a cell proliferative disorder, such as cancer, are provided utilizing analysis of target mutant nucleic acids in saliva specimens. The presence of the target mutant nucleic acids is indicative of a neoplastic disorder of the lung or the head and neck.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5382510 (1995-01-01), Levine et al.
patent: 5496699 (1996-03-01), Sorenson
patent: 5527676 (1996-06-01), Vogelstein et al.
patent: 5543296 (1996-08-01), Sobol et al.
patent: 5561041 (1996-10-01), Sidransky
patent: 5589579 (1996-12-01), Torczynski et al.
patent: 5726019 (1998-03-01), Sidransky
patent: 5952170 (1999-09-01), Stroun et al.
patent: 6150100 (2000-11-01), Ruschoff et al.
patent: 6235470 (2001-05-01), Sidransky
patent: 0 390 323 (1990-10-01), None
patent: 0 520 794 (1992-12-01), None
patent: WO 93/20235 (1993-10-01), None
patent: WO 93/22456 (1993-11-01), None
patent: WO 98/44158 (1998-10-01), None
Clarke et al,, Review Molecular biology chain reaction made easy. The polymerase chain reaction. Histochemical Journal 24, 913-926 (1992).
Kimpton et al., Automated DNA profiling employing multiplex amplification of short tandem repeat loci, PCR Methods Appl. 1993 3: 13-22.
Genbank Accession No. HUMUT211, Mar. 25, 1994.
Auffermann et al., “Early Detection of Precancerous Lesions in Dysplasias of the Lung by Rapid DNA Image Cytometry,” Received for Publication Jun. 18, 1984,The International Academy of Cytology, West Germany.
Auffermann et al., “Early Detection of Precancerous Lesions in Dysplasias of the Lung by Rapid DNA Image Cytometry,”Anal Quant Cytol Histol(US) vol. 7, No. 3, 1985, pp. 218-226.
Boyle et al., “The Incidence of p53 Mutations Increases with Progression of Head and Neck Cancer,”Cancer Research, vol. 53, 1993, pp. 4477-4480.
Chen et al., “The Diagnostic Significance of Determination of Secretory Immunoglobulin A In Sputum and Saliva in Lung Cancer,”Chinese Journal of Tuberculosis and Respiratory Diseases, vol. 8, No. 6, 1985, Database accession No. PREV198682035900, Abstract (pp. 325-327).
Fearon et al., “Identification of a Chromosome 18q Gene That Is Altered in Colorectal Cancers,”Science, vol. 247, No. 5, 1990, pp. 49-56.
Goyette et al., “Progression of Colorectal Cancer Is Associated with Multiple Tumor Suppressor Gene Defects but Inhibition of Tumorigenicity Is Accomplished by Correction of Any Single Defect via Chromosome Transfer,”Molecular and Cellular Biology, vol. 12, No. 3, 1992, pp. 1387-1395.
Hampton et al., “Simultaneous Assessment of Loss of Heterozygosity at Multiple Microsatellite Loci Using Semi-Automated Fluorescence-Based Detection: Subregional Mapping of Chromosome 4 in Cervical Carcinoma,”Proc. Natl. Acad. Sci. USA, vol. 93, 1996, pp. 6704-6709.
Kinzler et al., “Identification of a Gene Located at Chromosome 5q21 That is Mutated in Colorectal Cancers,”Science, vol. 251, No. 15, 1991, pp. 1366-1370.
Mao et al., “Detection of Oncogene Mutations In Sputum Precedes Diagnosis of Lung Cancer,”Cancer Research, vol. 54, No. 7, 1994, pp. 1634-1637.
Miyoshi et al., “Germ-Line Mutations of the APC Gene in 53 Familial Adenomatous Polyposis Patients,”Proc. Natl. Acad. Sci. USA, vol. 89, 1992, pp. 4452-4456.
Nasiell et al., “Cytomorphological Grading and Feulgen DNA Analysis of Metaplastic and Neoplastic Bronchial Cells,”Cancer, vol. 41, 1978, pp. 1511-1521.
Nishisho et al., “Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients,”Science, vol. 253, No. 9, 1991, pp. 665-669.
Powell, Steven M., “Molecular Diagnosis of Familial Adenomatous Polyposis,”New England Journal of Medicine, vol. 329, No. 27, 1993, pp. 1982-1987.
Saranath et al., “Molecular Lesions in Human Oral Cancer: The Indian Scene,”Oral Oncol Eur J Cancer, vol. 29B, No. 2, 1993, pp. 107-112.
Sidransky et al., “Identification of p53 Gene Mutation in Bladder Cancers and Urine Samples,”Science, vol. 252, 1991, pp. 706-709.
Sidransky et al., “Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors,”Science, vol. 256, 1992, pp. 102-105.
Sidransky, David, “Molecular Screening—Prospects for a New Approach,”Arch Otolaryngol Head and Neck Surgery, vol. 119, 1993, pp. 1187-1190.
Sidransky, David, “Oncogene Mutations as Intermediate Markers,”Journal of Cellular Biochemistry, Supplement 17F, 1993, pp. 184-187.
Sidransky, David, “Nucleic Acid-Based Methods for the Detection of Cancer,”Science, vol. 278, 1997, pp. 1054-1058.
Takeda et al., “Detection of K-ras Mutation in Sputum by Mutant-Allele-Specific Amplification (MASA),” 1993,Wiley-Liss, Inc., Department of Biochemistry, Cancer Institute, Toshima, Tokyo, Japan.
Takeda et al., “Detection of K-ras Mutation in Sputum by Mutant-Allele-Specific Amplification (MASA),”Human Mutation, vol. 2, 1993, pp. 112-117.
Verlaan-de Vries et al., “A Dot-Blot Screening Procedure for MutatedrasOncogenes Using Synthetic Oligodeoxynucleotides,”Gene, vol. 50, 1986, pp. 313-320.
A Non-final Rejection dated Sep. 7, 1994 (U.S. Appl. No. 08/152,313).
A Final Rejection dated Mar. 3, 1995 (U.S. Appl. No. 08/152,313).
An Advisory Action dated Sep. 5, 1995 (U.S. Appl. No. 08/152,313).
A Notice of Allowance dated Sep. 28, 1995 (U.S. Appl. No. 08/152,313).
A Non-final Rejection dated Nov. 12, 1996 (U.S. Appl. No. 08/579,223).
A Notice of Allowance dated May 5, 1997 (U.S. Appl. No. 08/579,223).
A Non-final Rejection dated Jul. 1, 1999 (U.S. Appl. No. 09/038,637).
A Final Rejection dated Mar. 1, 2000 (U.S. Appl. No. 09/038,637).
A Notice of Allowance dated Dec. 18, 2000 (U.S. Appl. No. 09/038,637).
A Non-final Rejection dated Mar. 27, 2002 (U.S. Appl. No. 09/863,806).
A Non-final Rejection dated Jul. 14, 2003 (U.S. Appl. No. 09/863,806).
A Non-final Rejection dated Nov. 2, 2006 (U.S. Appl. No. 10/754,478).
A Notice of Allowance dated Jun. 1, 2007 (U.S. Appl. No. 10/754,478).
DLA Piper (LLP) US
Horlick Kenneth R.
Staples Mark
The Johns Hopkins University School of Medicine
LandOfFree
Detection of nucleic acid mutation associated with cancer by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of nucleic acid mutation associated with cancer by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of nucleic acid mutation associated with cancer by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4122052